ArticlePloS one2025
Prevalence of antibiotic-resistant Escherichia coli isolates from healthy chicken droppings.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Luteolin ameliorates Escherichia coli-induced intestinal injury by modulating gut microbiota, metabolites and the TLR4/MyD88/NF-kB signaling pathway.Poultry science · 2026Article
- Antimicrobial use and resistance profiles of Escherichia coli and Campylobacter species from small-scale poultry farms in Central Kenya.BMC veterinary research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe increasing emergence of antimicrobial-resistant (AMR) Escherichia coli in poultry represents significant public health concern due to the risk of zoonotic transmission via the food chain. This study investigates the prevalence and resistance patterns of E. coli isolated from healthy broiler and indigenous chickens in Kifri City, Kurdistan Region, Iraq.
methodsA total of 200 cloacal swab samples were collected from healthy chickens (100 broilers and 100 indigenous). Standard bacteriological methods were used for E. coli isolation, followed by antimicrobial susceptibility testing against ten antibiotics using the Kirby-Bauer disc diffusion method. Additionally, molecular detection of resistance genes was performed via PCR.
resultsThe overall isolation rate of E. coli was 60%. Broiler isolates exhibited significantly higher resistance rates, including 100% resistance to ciprofloxacin and enrofloxacin, and >90% resistance to amoxicillin, amoxicillin-clavulanate, norfloxacin, and nitrofurantoin. In contrast, indigenous chicken isolates showed lower resistance, with the highest rates seen for amoxicillin-clavulanate (90%) and nitrofurantoin (85%). PCR analysis identified the presence of key resistance genes including blaTEM, qnrS, and sul1 among multidrug-resistant isolates. Statistically significant differences (p < 0.05) were observed in resistance profiles between broiler and indigenous groups.
conclusionThe high prevalence of multidrug-resistant E. coli in broiler chickens underscores the urgent need for stricter antibiotic stewardship in poultry farming. The findings support Sustainable Development Goals (SDGs) 3 (Good Health and Well-being), 12 (Responsible Consumption and Production), and 15 (Life on Land) by promoting antimicrobial surveillance and sustainable livestock management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.